Evidence for the transmission of plasmodium vivax in the Republic of the Congo, West Central Africa

Journal of Infectious Diseases

Volumn 200, Issue 9, 2009, Pages 1465-1469

  Culleton, Richard ^a,c   Ndounga, Mathieu ^e   Zeyrek, Fadile Yildiz ^f   Coban, Cevayir ^b   Casimiro, Prisca Nadine ^e   Takeo, Satoru ^d   Tsuboi, Takafumi ^d   Yadava, Anjali ^h   Carter, Richard ^g   Tanabe, Kazuyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d EHIME UNIVERSITY   (Japan)

^e Centre DEtudes sur les Resources Vegetales   (Italy)

^f HARRAN UNIVERSITY   (Turkey)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; MEROZOITE SURFACE PROTEIN 1;

ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD SAMPLING; BLOODSTREAM INFECTION; CONGO; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM VIVAX; POPULATION RESEARCH; PRIORITY JOURNAL; SEROLOGY;

ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; CONGO; ENDEMIC DISEASES; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MEROZOITE SURFACE PROTEIN 1; POPULATION SURVEILLANCE; PREVALENCE; PROTOZOAN PROTEINS; SEROLOGIC TESTS;

EID: 72849129091     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/644510     Document Type: Article

References (13)

1. Cvalli-Sforza LL. Africa: the history and geography of human genes. Princeton, NJ: Princeton University Press, 1994:158194.
2. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks: the Duffy-blood-group genotype, FyFy. N Engl J Med 1976; 295:302-314.
3. Culleton RL, Mita T, Ndounga M, et al. Failure to detect Plasmodium vivax inWest and Central Africa by PCR species typing. Malar J 2008;7: 174.
4. Cavasini CE, Mattos LC, Couto AA, et al. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans R Soc Trop Med Hyg 2007; 101:1042-4.
5. Ryan JR, Stoute JA, Amon J, et al. Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in Western Kenya. Am J Trop Med Hyg 2006; 75:575-81.
6. Rosenberg R. Plasmodium vivax in Africa: hidden in plain sight? Trends Parasitol 2007; 23:193-6.
7. Herrera S, Gómez A, Vera O, et al. Antibody response to Plasmodium vivax antigens in Fy-negative individuals from the Colombian Pacific coast. Am J Trop Med Hyg 2005; 73:44-9.
8. Yadava A, Sattabongkot J, Washington MA, et al. A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites. Infect Immun 2007; 75:117785.
9. Tsuboi T, Takeo S, Iriko H, et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun 2008; 76:1702-8.
10. Tolle R, Fruh K, Doumbo O, et al. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect Immun 1993; 61:40-7.
11. Olsson ML, Hansson C, Avent ND, Akesson IE, Green CA, Daniels GL. A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Transfusion 1998; 38:168-73.
12. Guerin-Marchand C, Druilhe P, Galey B, et al. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 1987; 329:164-7.
13. Belnoue E, Costa FT, Frankenberg T, et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004; 172:2487-95.